August 07, 2018
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Visual acuity gains demonstrated in PEACHTREE trial
VANCOUVER, British Columbia — Steven Yeh, MD, describes efficacy and safety findings from the PEACHTREE trial, which he presented at the American Society of Retina Specialists annual meeting. Patients who received suprachoroidal CLS-TA (Clearside Biomedical) for macular edema due to noninfectious uveitis achieved clinically meaningful visual acuity improvement at week 24 after two injections, one at baseline and one at week 12.